Thiazides
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
437 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | 15 | 15 | 83 | 109 | 54 | 274 |
| Essential hypertension | D000075222 | — | I10 | 4 | 5 | 29 | 12 | 5 | 53 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 5 | 6 | 1 | 13 | 6 | 31 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 5 | 5 | 2 | 11 | 4 | 27 |
| Heart failure | D006333 | EFO_0003144 | I50 | 2 | — | 3 | 8 | 5 | 18 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 1 | 3 | 8 | 4 | 17 |
| Chronic renal insufficiency | D051436 | — | N18 | 1 | 1 | 1 | 8 | 3 | 14 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | 6 | 3 | 4 | 13 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 2 | — | — | 8 | — | 10 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 2 | 5 | 1 | 2 | — | 10 |
Show 51 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 31 | — | 1 | — | 8 | 40 |
| Nephrolithiasis | D053040 | — | N20.0 | — | 2 | 2 | — | 3 | 6 |
| Vascular diseases | D014652 | EFO_0004264 | I77 | — | — | 1 | — | 4 | 5 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | 2 | — | 2 | 4 |
| Hyperinsulinism | D006946 | — | E16.1 | 2 | 1 | 1 | — | — | 4 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | 2 | — | — | 2 |
| Neoplasms | D009369 | — | C80 | — | — | 2 | — | — | 2 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | 1 | — | 1 | 2 |
| Acute kidney injury | D058186 | — | N17 | — | — | 1 | — | 1 | 2 |
| Hypercholesterolemia | D006937 | — | — | — | — | 1 | — | — | 1 |
Show 15 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cognitive dysfunction | D060825 | — | G31.84 | — | 1 | — | — | 4 | 5 |
| Hypercalciuria | D053565 | — | R82.994 | — | 1 | — | — | 4 | 5 |
| Ischemic stroke | D000083242 | — | — | — | 1 | — | — | 3 | 4 |
| Aging | D000375 | GO_0007568 | R41.81 | — | 2 | — | — | 1 | 3 |
| Ischemia | D007511 | EFO_0000556 | — | — | 1 | — | — | 2 | 3 |
| Hyperlipidemias | D006949 | EFO_0003774 | E78.5 | — | 1 | — | — | 1 | 2 |
| Prediabetic state | D011236 | EFO_1001121 | R73.03 | 1 | 1 | — | — | — | 2 |
| Critical illness | D016638 | — | — | — | 1 | — | — | 1 | 2 |
| Sedentary behavior | D057185 | — | — | — | 1 | — | — | — | 1 |
| Sexual infantilism | D050035 | — | — | — | 1 | — | — | — | 1 |
Show 6 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Therapeutic equivalency | D013810 | — | — | 4 | — | — | — | — | 4 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | 2 | — | — | — | 2 | 4 |
| Fasting | D005215 | EFO_0002756 | — | 2 | — | — | — | — | 2 |
| Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | 1 | — | — | — | 1 | 2 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | 2 | — | — | — | — | 2 |
| Fatty liver | D005234 | EFO_0003934 | — | 1 | — | — | — | 1 | 2 |
| Myocardial stunning | D017682 | — | — | 2 | — | — | — | — | 2 |
| Pure autonomic failure | D054970 | — | — | 1 | — | — | — | — | 1 |
| Drug interactions | D004347 | — | — | 1 | — | — | — | — | 1 |
| Chronic pain | D059350 | — | — | 1 | — | — | — | — | 1 |
Show 4 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hyponatremia | D007010 | — | E87.1 | — | — | — | — | 4 | 4 |
| Gitelman syndrome | D053579 | Orphanet_358 | N15.8 | — | — | — | — | 2 | 2 |
| Disease | D004194 | EFO_0000408 | R69 | — | — | — | — | 2 | 2 |
| Nephritis | D009393 | — | N05 | — | — | — | — | 1 | 1 |
| Coronary vasospasm | D003329 | EFO_0004225 | — | — | — | — | — | 1 | 1 |
| Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | — | — | 1 | 1 |
| Peripheral vascular diseases | D016491 | EFO_0003875 | I73.9 | — | — | — | — | 1 | 1 |
| Calcium metabolism disorders | D002128 | EFO_0005769 | E83.5 | — | — | — | — | 1 | 1 |
| Reperfusion injury | D015427 | — | — | — | — | — | — | 1 | 1 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | — | — | — | 1 | 1 |
Show 23 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
31 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use